At Telomir Pharmaceuticals, we are committed to developing breakthrough science to address the root causes of difficult to treat diseases. By partnering with the brightest minds in science and healthcare, we have the potential to discover and develop ground-breaking treatments to bring about better health for patients and change the future of medicine.
Company Profile
Contact Information
Investor Relations
KCSA
Phil Carlson
261 Madison Avenue, 9th Fl.
New York, NY 10016
T: 212-896-1233
telomir@kcsa.com
Company Contact
Telomir Pharmaceuticals, Inc.
855 Wolfe St.
Ste 601.1
Baltimore, MD 21205
United States
T: 813-864-2558
telomir@kcsa.com